Extracted from this filing and checked against the source text.
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
CANNAPHARMARX, INC. completed an acquisition involving Amir Tal and Koze Investments LLC for shares of our Class C Convertible Preferred Stock, par value $1.00 per share, each share of which is convertible into shares of our Common Stock, which represen (closed 2023-11-22).
- Action
- acquisition
- Counterparty
- Amir Tal and Koze Investments LLC
- Consideration
- shares of our Class C Convertible Preferred Stock, par value $1.00 per share, each share of which is convertible into shares of our Common Stock, which represen
- Closing
- 2023-11-22
Exact text from the filing
us to all of the profits and losses of LTB. Consideration due to the Sellers under the Transaction consists of shares of our Class C Convertible Preferred Stock, par value $1.00 per share, each share of which is convertible into shares of our Common Stock, which represents a 33% ownership interest based on our fully-diluted capitalization immediately
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
CANNAPHARMARX, INC. entered into Amended and Restated Membership Interest Purchase Agreement with Amir Tal and Koze Investments LLC (effective 2023-11-22).
- Action
- entry
- Agreement
- asset purchase
- Counterparty
- Amir Tal and Koze Investments LLC
- Effective
- 2023-11-22
Exact text from the filing
On November 22, 2023, CannaPharmaRX, Inc. (the “Company,” “we,” “our,” or “us”), entered into an Amended and Restated Membership Interest Purchase Agreement (the “Purchase Agreement”) by and among us and Amir Tal and Koze Investments LLC (the “Sellers”) whereby we acquired all of the Class B Member Interests in LTB Management, LLC
View on SEC.gov